SBUX vs SGMO · P/E 76, rev $37.18B vs rev $57.8M
Starbucks Corporation (SBUX) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Starbucks Corporation (SBUX) is a restaurants company listed on NASDAQ. It is led by Brian Niccol.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported SBUX revenue for 2025-09-28 was $37.18B. Net income was $1.86B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
SBUX currently screens at market cap $113.76B and trailing P/E 76.2. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the SBUX and SGMO stock pages for the full models.
Not investment advice.